UBE Corporation

DB:UBE Stock Report

Market Cap: €1.4b

UBE Valuation

Is UBE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of UBE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: UBE (€14) is trading below our estimate of fair value (€20.19)

Significantly Below Fair Value: UBE is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for UBE?

Key metric: As UBE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for UBE. This is calculated by dividing UBE's market cap by their current earnings.
What is UBE's PE Ratio?
PE Ratio11x
EarningsJP¥20.28b
Market CapJP¥224.01b

Price to Earnings Ratio vs Peers

How does UBE's PE Ratio compare to its peers?

The above table shows the PE ratio for UBE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average49.4x
BAS BASF
76.9x34.2%€38.2b
SDF K+S
79.4x61.3%€2.0b
WCH Wacker Chemie
29.1x37.0%€3.6b
ACT AlzChem Group
12.2x12.6%€610.6m
UBE UBE
11x14.0%€224.0b

Price-To-Earnings vs Peers: UBE is good value based on its Price-To-Earnings Ratio (11x) compared to the peer average (49.4x).

Price to Earnings Ratio vs Industry

How does UBE's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
UBE 11.0xIndustry Avg. 17.0xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: UBE is good value based on its Price-To-Earnings Ratio (11x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is UBE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UBE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11x
Fair PE Ratio14.4x

Price-To-Earnings vs Fair Ratio: UBE is good value based on its Price-To-Earnings Ratio (11x) compared to the estimated Fair Price-To-Earnings Ratio (14.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst UBE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€14.00
€19.58
+39.8%
12.3%€23.80€17.69n/a6
Nov ’25€14.90
€19.02
+27.7%
15.4%€23.73€14.97n/a6
Oct ’25€16.60
€19.76
+19.0%
15.4%€24.65€15.55n/a6
Sep ’25€16.40
€18.96
+15.6%
11.3%€22.30€15.24n/a6
Aug ’25€15.90
€18.23
+14.6%
12.2%€20.66€14.12n/a6
Jul ’25€16.30
€18.36
+12.7%
13.8%€21.38€14.61n/a6
Jun ’25€16.90
€16.87
-0.2%
13.8%€21.56€14.73n/a6
May ’25€17.10
€16.87
-1.3%
13.8%€21.56€14.73n/a6
Apr ’25€16.30
€17.16
+5.3%
13.8%€21.93€14.98n/a6
Mar ’25€15.40
€16.05
+4.2%
14.4%€18.51€12.03n/a5
Feb ’25€15.10
€16.51
+9.3%
13.2%€18.70€12.58n/a5
Jan ’25€14.50
€16.51
+13.9%
13.2%€18.70€12.58n/a5
Dec ’24€14.20
€16.63
+17.1%
13.7%€20.26€12.89n/a6
Nov ’24€14.70
€17.24
+17.3%
14.0%€20.85€13.27€14.906
Oct ’24€15.80
€17.05
+7.9%
16.0%€20.95€12.70€16.606
Sep ’24€15.60
€17.05
+9.3%
16.0%€20.95€12.70€16.406
Aug ’24€16.50
€16.96
+2.8%
17.1%€21.16€12.82€15.906
Jul ’24€15.40
€16.11
+4.6%
15.1%€19.69€12.70€16.306
Jun ’24€14.80
€14.73
-0.4%
14.8%€19.01€12.22€16.906
May ’24€14.10
€14.87
+5.5%
14.8%€19.19€12.34€17.106
Apr ’24€13.90
€14.66
+5.5%
12.7%€18.12€12.55€16.306
Mar ’24€13.90
€14.66
+5.5%
12.7%€18.12€12.55€15.406
Feb ’24€14.30
€15.80
+10.5%
17.1%€20.24€13.01€15.106
Jan ’24€13.50
€15.76
+16.8%
21.7%€21.53€12.50€14.506
Dec ’23€13.70
€16.09
+17.4%
19.7%€21.50€13.52€14.206
Nov ’23€12.80
€17.00
+32.8%
20.4%€21.80€13.71€14.706

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Transcontinental

CA$1.4b

Engages in the flexible packaging business in Canada, the United States, Latin America, the United Kingdom, Australia, and New Zealand.

53L

CA$11.10

7D

-1.8%

1Y

53.1%

Trinseo

US$120.4m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

3XD

US$3.10

7D

-2.5%

1Y

-48.8%

Compañía de Minas BuenaventuraA

US$3.2b

Engages in the exploration, development, construction, and operation of mineral processing business.

MBU

US$11.60

7D

6.4%

1Y

45.9%